OC-0156: MRI only prostate radiotherapy using synthetic CT images  by Persson, E. et al.
S72                                                                                     ESTRO 35 2016 
 _____________________________________________________________________________________________________ 
calculation revealed highly consistent results between the 




Conclusion: A multi-atlas based approach was presented in 
this work for generation of the synthetic CT for MR only 
radiotherapy of the head & neck cancer patients. While the 
registration scheme presented in this work enhances the 
performance of the atlas propagation, generalized 
registration error (GRE) helps to construct a better synthetic 
CT using a locally more similar atlas. 
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Purpose or Objective: Introducing an MRI-only workflow into 
the radiotherapy clinic, requires that MR-images can be used 
both for treatment planning calculations and for patient 
positioning. The two-fold aim of this study was to evaluate 
the use of MR-images with respect to 1) the accuracy of 
treatment planning dose calculations, and 2) the reliability of 
fiducial marker identification for patient positioning. 
 
Material and Methods: Synthetic CT images (sCT) were 
generated using the Statistical Decomposition Algorithm 
(SDA, MriPlanner, Spectronic Medical AB, Sweden). The 
algorithm uses a T2-weighted MRI for sCT generation, based 
on a multi-template assisted classification method. In order 
to exclude the effect of geometrical distortions and patient 
deformation owing to reposition between imaging sessions, a 
registered CT (rCT) was constructed by deformable 




Five-field IMRT plans (both 6 and 10 MV) were created for six 
patients, using the Eclipse treatment planning system (Varian 
Medical Systems, Palo Alto, CA). Final dose calculations were 
made using the anisotropic analytical algorithm (AAA). The 
rCT was used for the initial treatment planning and the plan 
was recalculated on the sCT. Thus, the two treatment plans 
created for each patient had the same number of monitor 
units for each field. The resulting dose distributions from the 
rCT- and sCT-treatment plans were compared based on a set 
of dose volume histogram criteria according, and by using 
gamma evaluation.  
The reliability of the MRI-based fiducial marker identification 
was evaluated by an observer study. For this part of the 
study, the position of gold fiducial markers were determined 
by six independent observers using an MRI sequence 
dedicated for marker identification (LAVA-flex). Each marker 
position, three for each patient, were compared between the 
observers. The observers graded (one to five, were five 
represents the highest level of confidence) their confidence 
by which the markers for each patient were identified. 
 
Results: The mean dose differences to PTV between plans 
based on sCT and rCT were -0.1%±0.3% (1 s.d) (6MV) and -
0.2%±0.2% (1 s.d) (10 MV). Gamma analysis showed pass rates 
ranging between 98% and 100% for both energies, with 
gamma criteria of 1%/2mm (local dose deviation). The mean 
standard deviation of the marker position, as determined by 
the observers, was 0.6 mm in all directions (x, y and z). One 
marker identification result was excluded due to an incorrect 
identification by one observer. The confidence grading 
ranged between 2 and 5. 
 
Conclusion: This work demonstrates that SDA can provide 
sufficient dosimetric accuracy for an MRI only workflow for 
prostate cancer patients. However, gold fiducials cannot be 
identified using LAVA-flex with high enough confidence and 
further work is needed to develop methods for marker 
identification in an MRI only workflow. 
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Purpose or Objective: Prostate cancer patients scheduled 
for EBRT are often implanted with fiducial markers for 
position verification. A precondition for an MR-only workflow 
is the possibility to identify them on MRI. The markers 
present as signal voids in most images and their apparent 
position depends on their shape and orientation relative to 
the magnetic field. Rather than acquiring a sequence for this 
single purpose, we propose to use a model for the automatic 
detection of fiducial markers combining information from the 
entire multiparametric (mp) MRI protocol used for target 
delineation. 
 
Material and Methods: Thirty prostate cancer patients 
scheduled for EBRT were implanted with 2-3 gold fiducial 
markers (0.9x3mm). A mp-MRI (T1w, T2w, B0-mapping and 
mDIXON) was performed using a 3T MRI (Achieva, Philips) and 
a CT with a 24-slice CT scanner (Somatom-Sensation-Open, 
Siemens).The reference position of the markers was based on 
the segmented CT images. The MRI was registered to the CT 
and resampled to the grid of 0.9x0.9x3mm3. A logistic 
regression model was developed to estimate the location of 
the markers based on the following MRI features: signal 
intensity, mean, median, min, max and standard deviation 
values in a kernel of 3x3x3vox and a multi-scale blobness 
filter [1] of the prostate region. The model was cross-
validated using a leave-one-out method. Performance was 
assessed using features from each separate imaging sequence 
and by combining the features from all sequences. Voxels 
detected as markers by the model were grouped into 
clusters. We defined the probability of each cluster 
candidate as the highest probability value of all voxels within 
it. Results were further post-processed by selecting the n(i) 
highest probability clusters, where n(i) is the number of 
markers implanted in patient i. Results were classified as a 
false positive (FP) if the distance between the reference 
